Evaluation of 3D Rotational Angiography After EVAR
- Conditions
- Radiation BurnAortic Aneurysm, Abdominal
- Registration Number
- NCT02894749
- Lead Sponsor
- University Hospital, Lille
- Brief Summary
This is a randomized prospective monocentric study to evaluate the benefits of a 3D rotational acquisition (3DRA) to assess technical success after treatment of infra-renal aneurysm with bifurcated endograft. Patients will be randomized between the standard strategy (2D angiography at the end of the procedure and angioCT-scan before discharge) and the new strategy (3DRA at the end of the procedure). Expected findings are a reduction of radiation exposure and contrast medium used during the hospital stay, with a similar resolution between angioCT-scan and 3DRA to depict the main complications after EVAR (occlusion, kinking, endoleak). Furthermore, any complication depicted after 3DRA group could benefit from an additional procedure during the same operating time, and therefore avoid a second intervention for the patient.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients treated with EVAR for infra-renal aortic aneurysm
- In a hybrid room
- With a signed consent
- Pregnant women
- Patients unable to understand the study protocol or to give their consents
- Renal insufficiency (eGFR<60mL/min)
- Ruptured aneurysms and other emergency settings
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Effective Dose Single 1 day - At patient discharge Total exposure to radiation in mSv
- Secondary Outcome Measures
Name Time Method Reintervention rate During the first 30 days Number of secondary procedures due to initial technical issues in both group during the first month
Contrast Medium Single 1 day - At patient discharge Total amount of contrast medium used (mg of Iodine)
Additional procedure During surgery Number of additional unplanned procedures during the initial operating time, thanks to complications depicted by respectively the 2D angiography or the 3D rotational angiography.
Trial Locations
- Locations (1)
Hôpital Cardiologique, CHRU
🇫🇷Lille, France
Hôpital Cardiologique, CHRU🇫🇷Lille, France